X

Download Blood Pressure Monitoring PowerPoint Presentation


Login   OR  Register
X

Share page



  Preview

               
Home / Health & Wellness / Health & Wellness Presentations / Blood Pressure Monitoring PowerPoint Presentation

Blood Pressure Monitoring PowerPoint Presentation

onlinesearch By : onlinesearch

On : Mar 14, 2014

In : Health & Wellness

Embed :
901
views

0
downloads
Login / Signup - with account for


  • → Make favorite
  • → Flag as inappropriate
  • → Download Presentation
  • → Share Presentation
  • Slide 1 - Blood Pressure Monitoring www.bhsoc.org
  • Slide 2 - BHS Classification of BP Levels This classification equates with that of the WHO/ISH (2) and is based on clinical BP values. If SBP and DBP fall into different categories the higher value should be taken for classification.
  • Slide 3 - Blood pressure measurement by standard mercury sphygmomanometer or semi-automated device Follow BHS guidelines on technique (15) Use device with validated accuracy, that is properly maintained and calibrated Measure sitting BP routinely: standing BP in elderly or diabetic patients Remove tight clothing, support arm at heart level, ensure hand relaxed Use cuff of appropriate size Lower mercury column slowly, by 2mm per second Read BP to the nearest 2 mmHg Measure diastolic as disappearance of sounds (phase V) Take the mean of at least two readings, more recordings are needed if marked differences between initial measurements are found Use the average for several visits when estimating cardiovascular risk in mild hypertension
  • Slide 4 - BP cuff sizes for mercury sphygmomanometer, semi-automatic and ambulatory monitors Standard cuffs are sometimes recommended (size 12 x 35cm) but can result in problems with overcuffing. The BHS recommends cuff size is selected on arm circumference.
  • Slide 5 - Threshold levels of BP for the diagnosis of Hypertension according to measurement method These figures do not necessarily equate with the need for antihypertensive drug treatment to be started and therapy must be based on overall CV risk as well as absolute BP levels. Antihypertensive treatment should however, be initiated in people with sustained office SBP >160mmHg or sustained DBP >100mmHg irrespective of other risk factors. Lower levels of BP to initiate drug therapy may be considered in some instances eg post-stroke, diabetes The highest value of SBP or DBP should be used for classification, whichever method measurement method is used
  • Slide 6 - Potential indications for Ambulatory Blood Pressure Monitoring When BP shows unusual variability In excluding white coat hypertension In helping with the assessment of patients with borderline hypertension In identifying nocturnal hypertension In assessing patients whose hypertension has been resistant to drug therapy (defined as BP >150/90mmHg on 3 or more antihypertensive drugs) As a guide to determining the efficacy of drug treatment over 24 hours In diagnosing and treating hypertension in pregnancy In diagnosing hypotension and postural hypotension
  • Slide 7 - Suggested target blood pressures during antihypertensive treatment Systolic and diastolic should both be attained eg <140/85 mmHg means less than 140 mmHg systolic and less than 85 mmHg diastolic Audit standard reflects the minimum recommended levels of BP control Despite best practice, the Audit Standard will not be achievable in all treated hypertensives
  • Slide 8 - White Coat Hypertension Definition Blood pressure >149/90 mmHg when measured in office Normal daytime ambulatory pressure <135/85 mmHg Prevalence of white coat hypertension 10-30% of general population Common in elderly people and pregnant women Risks Less than from sustained hypertension Probably small risk when compared with people with normal blood pressure Possibly a precursor to hypertension Clinical Implications No clinical characteristics assist in diagnosis Must be considered in people newly diagnosed with hypertension Should be considered before drug treatment is prescribed (could lead to fewer drugs being prescribed) Must be placed in context of the overall risk profile Should reassure patients, employers and insurers that risk from white coat hypertension is low or absent Patients need follow up re-monitoring
  • Slide 9 - Considerations for anti-hypertensive treatment in older people Absolute benefit from treatment is greater in the elderly than younger age groups Ages 65-79 years treat if SBP >160mmHg and/or DBP is >100mmHg or if BP >140 and/or 90mmHg and CV risk is >2.0% per annum or TOD present Ages >80 years newly diagnosed with TOD and/or other risk factors – treatment probably of benefit Ages >80 years newly diagnosed without TOD/risk factors – benefit of treatment unknown Ages >80 years on treatment with TOD/risk factors – treatment should probably be continued Ages >80 years on treatment without TOD or other risk factors – benefits of treatment unknown
  • Slide 10 - Controlling CV risk in the elderly Level of BP reduction is more important than specific drug used in older hypertensives whether diabetic or non-diabetic. BP targets for those aged <80 years are similar to those for younger patients Other CV risk factors must be addressed and aspirin considered for primary and secondary CV risk prevention Non-pharmacological measures should be considered in all patients and used in conjunction with anti-hypertensive drugs Thiazide diuretics remain first line agents of choice in this age group though for those with ISH or are diuretic intolerant, CCB’s are a good alternative. α- and β- blockers are unproven as effective initial agents in most older people Two or more anti-hypertensive drug classes will be needed in the majority of patients, fixed dose combinations may improve compliance
  • Slide 11 - Cerebrovascular Disease Increasing BP levels are a significant risk factor for primary stroke and recurrence even in the very elderly Following acute stroke BP levels are frequently raised and fall spontaneously over the next few days. Both high and low BP levels immediately post-stroke are associated with an adverse prognosis There is no evidence yet as to whether anti-hypertensive drugs should be started immediately after stroke or if current medication should be continued in the acute post-ictal phase Diuretics and/or ACEIs reduce the risk of stroke recurrence and major CV events by about 20-30% in those with a history of stroke or TIA whether normotensive or hypertensive at follow-up To realise the full potential in both primary and secondary stroke prevention, other risk factors must be treated
Sperm Free PowerPoint Template

Sperm

Views : 867

Potter Free PowerPoint Template

Potter

Views : 671

Time Management Free PowerPoint Template

Time Management

Views : 549

Running Track Free PowerPoint Template

Running Track

Views : 485

Blood Cells Free PowerPoint Template

Blood Cells

Views : 950

Columns Free PowerPoint Template

Columns

Views : 401

Stopwatch Free PowerPoint Template

Stopwatch

Views : 624

Koli Bacteria Free PowerPoint Template

Koli Bacteria

Views : 1415

Morning Running Free PowerPoint Template

Morning Running

Views : 814

Earth Free PowerPoint Template

Earth

Views : 509

Open Book Free PowerPoint Template

Open Book

Views : 967

Firefighters Free PowerPoint Template

Firefighters

Views : 1318

Dental Test Free PowerPoint Template

Dental Test

Views : 459

Biology Free PowerPoint Template

Biology

Views : 525

SPA Free PowerPoint Template

SPA

Views : 1066

Email Symbol Free PowerPoint Template

Email Symbol

Views : 519

Ocean Free PowerPoint Template

Ocean

Views : 381

Email Free PowerPoint Template

Email

Views : 502

Yoga Free PowerPoint Template

Yoga

Views : 2484

Swans Free PowerPoint Template

Swans

Views : 469

Description : Available Blood Pressure Monitoring powerpoint presentation for free download which is uploaded by search an active user in belonging ppt presentation Health & Wellness category.

Tags : Blood Pressure Monitoring

Shortcode : Get Shareable link